US 6045789
Bystander effect tumoricidal therapy by expressing an HSV-tk gene
expired A61KA61K38/45A61K48/00
Quick answer
US patent 6045789 (Bystander effect tumoricidal therapy by expressing an HSV-tk gene) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/45, A61K48/00, A61P, A61P35/00